1. Home
  2. ROC vs VRCA Comparison

ROC vs VRCA Comparison

Compare ROC & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rank One Computing Corporation Common stock

ROC

Rank One Computing Corporation Common stock

N/A

Current Price

$5.12

Market Cap

100.6M

Sector

N/A

ML Signal

N/A

Logo Verrica Pharmaceuticals Inc.

VRCA

Verrica Pharmaceuticals Inc.

HOLD

Current Price

$6.40

Market Cap

117.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ROC
VRCA
Founded
2015
2013
Country
United States
United States
Employees
82
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
100.6M
117.5M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
ROC
VRCA
Price
$5.12
$6.40
Analyst Decision
Strong Buy
Buy
Analyst Count
1
2
Target Price
$9.00
$17.00
AVG Volume (30 Days)
66.3K
38.9K
Earning Date
03-31-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$35,577,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$94.44
P/E Ratio
N/A
N/A
Revenue Growth
N/A
370.22
52 Week Low
$3.71
$0.72
52 Week High
$7.80
$9.82

Technical Indicators

Market Signals
Indicator
ROC
VRCA
Relative Strength Index (RSI) 51.38 52.37
Support Level $4.42 $5.32
Resistance Level $5.32 $6.56
Average True Range (ATR) 0.60 0.55
MACD 0.03 0.05
Stochastic Oscillator 62.61 59.02

Price Performance

Historical Comparison
ROC
VRCA

About ROC Rank One Computing Corporation Common stock

Rank One Computing Corp is an American artificial intelligence company. It develops AI systems that analyze visual data to identify and interpret objects and activities. The company's focus is on biometric identity, digital forensics, and real-time video analytics. It uses the term 'Vision AI,' which is an operational AI built for accuracy, speed, and auditability. The company generates revenue from the sale of access to its software platforms, maintenance services, and professional services.

About VRCA Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc is a therapeutics company developing and commercializing medications for the treatment of dermatologic diseases, including skin cancers. Its commercial product and portfolio of product candidates are clinician administered therapies in areas of high unmet need. This product portfolio consists of one product with an approved indication for molluscum contagiosum, or molluscum, with the potential for several follow-on indications, as well as additional pipeline product candidates. Its commercial product, YCANTH (VP-102), for the treatment of molluscum in adult and pediatric patients two years of age and older. YCANTH (VP-102) is a proprietary drug-device combination that contains a GMP-controlled formulation of cantharidin.

Share on Social Networks: